Cargando…
COVID-19: consider cytokine storm syndromes and immunosuppression
Autores principales: | Mehta, Puja, McAuley, Daniel F, Brown, Michael, Sanchez, Emilie, Tattersall, Rachel S, Manson, Jessica J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270045/ https://www.ncbi.nlm.nih.gov/pubmed/32192578 http://dx.doi.org/10.1016/S0140-6736(20)30628-0 |
Ejemplares similares
-
Intravenous anakinra for cytokine storm syndromes – Authors' reply
por: Mehta, Puja, et al.
Publicado: (2020) -
Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome
por: Mehta, Puja, et al.
Publicado: (2020) -
Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
por: Peter, Angela E., et al.
Publicado: (2021) -
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections
por: Remy, Kenneth E., et al.
Publicado: (2020) -
CALM BEFORE THE STORM: COVID-19 AND CYTOKINE STORM SYNDROME
por: Chahal, Japjot, et al.
Publicado: (2020)